These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2145424)

  • 1. Beneficial effects of long-term treatment with SK&F 105685 in murine lupus nephritis.
    Albrightson-Winslow CR; Brickson B; King A; Olivera D; Short B; Saunders C; Badger AM
    J Pharmacol Exp Ther; 1990 Oct; 255(1):382-7. PubMed ID: 2145424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
    Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice.
    Zhao JH; Sun SJ; Horiguchi H; Arao Y; Kanamori N; Kikuchi A; Oguma E; Kayama F
    Int Immunopharmacol; 2005 Oct; 5(11):1601-10. PubMed ID: 16039550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506.
    Yamamoto K; Mori A; Nakahama T; Ito M; Okudaira H; Miyamoto T
    Immunology; 1990 Feb; 69(2):222-7. PubMed ID: 1689694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
    Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M
    Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice.
    Fujii T; Okada M; Fujita Y; Sato T; Tanaka M; Usui T; Umehara H; Mimori T
    J Autoimmun; 2009 Sep; 33(2):125-34. PubMed ID: 19596182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
    Tada Y; Nagasawa K; Ho A; Morito F; Koarada S; Ushiyama O; Suzuki N; Ohta A; Mak TW
    J Immunol; 1999 Sep; 163(6):3153-9. PubMed ID: 10477582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610.
    Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM
    J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
    J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.
    Kulkarni O; Eulberg D; Selve N; Zöllner S; Allam R; Pawar RD; Pfeiffer S; Segerer S; Klussmann S; Anders HJ
    J Pharmacol Exp Ther; 2009 Feb; 328(2):371-7. PubMed ID: 18997060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis.
    Shiraki M; Fujiwara M; Tomura S
    Clin Exp Immunol; 1984 Feb; 55(2):333-9. PubMed ID: 6607792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
    Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of end stage MRL-1pr/lpr mouse lupus disease by a cyclophosphazene derived drug and by cyclosporin A.
    In S; Dueymes M; Appolinaire-Pilipenko S; Sournies F; Labarre JF; Fournié GJ
    J Clin Lab Immunol; 1990 Jun; 32(2):85-90. PubMed ID: 1967044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
    Rodgers KE
    J Autoimmun; 1997 Aug; 10(4):367-73. PubMed ID: 9237800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Hagiwara E; Okubo T; Aoki I; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Okuda K; Miyazaki J; Ishigatsubo Y
    Cytokine; 2000 Jul; 12(7):1035-41. PubMed ID: 10880249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.